Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07555392 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

Study acronym: CHIKV/II-III
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 29, 2026 (before its estimated September 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A Seamless Phase II/III, Observer-blind, Multi-centre, Randomized Clinical Trial to Evaluate Immunogenicity and Safety of BBV87, an Inactivated Chikungunya Virus Vaccine in Healthy Subjects 12-65 Years of Age
Trial Details
NCT Number NCT07555392
Lead Sponsor Bharat Biotech International Limited
Conditions
(from sponsor)		 Active Immunisation for Chikungunya Virus Infection
Related terms Chikungunya Fever
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov